Expected to Ascend from $12.33 Billion in 2024 to $14.48 Billion in 2029 at a Steady CAGR: Analysis of Drivers and Trends in the Osteoporosis Drugs Market
What Is The Projected Market Size Of The Global Osteoporosis Drugs Market And Its Growth Rate?
• The osteoporosis drugs market size will grow from $12.33 billion in 2024 to $12.8 billion in 2025 at a compound annual growth rate (CAGR) of3.8%.
• The market is expected to rise to $14.48 billion in 2029 at a compound annual growth rate (CAGR) of 3.1%.
What Is Driving The Growth In The Osteoporosis Drugs Market?
The prevalence of osteoporosis has seen a significant surge, leading to an increase in demand for osteoporosis drugs. Osteoporosis is a disease affecting bone quality and density, particularly prevalent among individuals with a low calcium intake. The use of osteoporosis drugs facilitates an increase in bone mineral density, thereby assisting in the prevention of fractures. For instance, the Australian Institute of Health and Welfare reported that in 2022, osteoporosis accounted for 2,659 deaths, or 1.4% of all fatalities. Therefore, such increasing prevalence of osteoporosis is driving the growth of the osteoporosis drugs market.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9102&type=smp
Who Are the Key Players Driving Osteoporosis Drugs Market Growth?
• Pfizer Inc.
• F. Hoffmann La Roche Ltd.
• Merck & Co Inc.
• Novartis AG
• Bristol Myers Squibb Company
• GlaxoSmithKline PLC
• Eli Lilly and Company
• Amgen Inc.
• Novo Nordisk A/S
• Asahi Kasei Pharma Corporation
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd
• Mylan N.V.
• Daiichi Sankyo Company Limited
• Sun Pharmaceutical Industries Ltd.
• Ipsen, Kyowa Kirin Co Ltd.
• Dr. Reddy’s Laboratories Ltd.
• Cipla Limited
• Recordati S.p.A.
• Cadila Healthcare Ltd.
• Lupin Limited
• Torrent Pharmaceuticals Ltd.
• Sunovion Pharmaceuticals Inc.
• Theramex
• Radius Health Inc.
• Strides Pharma Science Limited
• Apotex Inc.
What Are The Key Trends In The Osteoporosis Drugs Market?
• Personalized medicine approaches
• Exploration of combination therapies
• Focus on fracture prevention strategies
• R&D investment in novel drug targets
• Collaborations for drug development
What Are The Segments Of The Global Osteoporosis Drugs Market?
• By Type: Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors
• By Administration: Oral, Injectable
• By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Sales
• By Application: Primary Osteoporosis, Secondary Osteoporosis
Which Region Leads The Osteoporosis Drugs Market?
North America was the largest region in the osteoporosis market in 2024. The regions covered in this report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report
What Is Covered In The Osteoporosis Drugs Market Global Market Report?
– Market Size Analysis: Analyze the Osteoporosis Drugs Market size by key regions, countries, product types, and applications.
– Market Segmentation Analysis: Identify various subsegments within the Osteoporosis Drugs Market for effective categorization.
– Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
– Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
– Market Contribution: Evaluate contributions of different segments to the overall Osteoporosis Drugs Market growth.
– Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
– Industry Challenges: Analyze challenges and risks affecting the Osteoporosis Drugs Market.
– Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=9102&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: mailto:info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Learn More About The Business Research Company
The Business Research Company ( https://www.thebusinessresearchcompany.com ) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC’s consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.